Prehabilitation program for cancer patients with Type 2 diabetes
Impact of a Multimodal Prehabilitation Programme on Markers of Health, Quality of Life and the Short and Long Post-surgery Recovery Period in Cancer Patients With Type 2 Diabetes
This study tests a health program that helps cancer patients with Type 2 diabetes get stronger and healthier before surgery by using exercise, nutrition tips, and support for anxiety.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Greenwich Academic / other |
| Locations | 2 sites (Eltham, England and 1 other locations) |
| Trial ID | NCT05547594 on ClinicalTrials.gov |
What this trial studies
This study focuses on a multimodal prehabilitation program designed for patients with cancer and non-insulin-dependent Type 2 diabetes who are awaiting surgery. The program aims to enhance patients' overall health and fitness through interventions such as physical activity, nutritional education, and coping strategies for anxiety. By leveraging existing NHS infrastructure, the study will analyze the impact of these prehabilitation efforts on various health markers and recovery outcomes. The approach may include both telehealth and in-person sessions to accommodate patient preferences.
Who should consider this trial
Good fit: Ideal candidates are newly diagnosed cancer patients with non-insulin-dependent Type 2 diabetes who are preparing for surgery.
Not a fit: Patients with medical contraindications to physical activity may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could lead to improved recovery and reduced complications for patients undergoing surgery.
How similar studies have performed: Other studies have shown positive outcomes with multimodal prehabilitation approaches, indicating potential for success in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Capacity to give consent * Newly diagnosed with cancer * Non-insulin-dependent Type 2 diabetes * Awaiting surgery for cancer Exclusion Criteria: * Medical contraindication to engage in physical activity
Where this trial is running
Eltham, England and 1 other locations
- School of Human Sciences, University of Greenwich, Avery Hill Campus, Sparrows Farm (Office SF112B) — Eltham, England, United Kingdom (Not_yet_recruiting)
- King's College Hospital — London, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Fernando Naclerio, PhD — University of Greenwich
- Study coordinator: Fernando Naclerio, PhD
- Email: f.j.naclerio@greenwich.ac.uk
- Phone: 0044 2083 318441
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.